Meridian Wealth Partners’s Aceragen Inc ACGN Stock Holding History

Meridian Wealth Partners’s Portfolio ACGN Stock Details ACGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3	Closed	–	–	1392
2021 Q1	$0	Buy	+3	New	+$225	﹤0.01%	1488

Other funds holding ACGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

HCM

Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return

Meridian Wealth Partners's ACGN Position: Q2 2021 in Review

Meridian Wealth Partners sold out of Aceragen Inc (ACGN) in Q2 2021, closing a stake of 3 shares.

Meridian Wealth Partners first reported a position in ACGN in Q1 2021 and held it in 1 quarter. The position peaked at $0 in Q1 2021. 47 funds tracked by Wall St. Rank hold ACGN as of Q2 2021.

Meridian Wealth Partners reported no remaining Aceragen Inc position as of Q2 2021 after selling out during the quarter.
Meridian Wealth Partners sold 3 Aceragen Inc shares in Q2 2021.
Meridian Wealth Partners first reported a position in Aceragen Inc in Q1 2021 and held it in 1 quarter.
Meridian Wealth Partners's Aceragen Inc position peaked at $0 in Q1 2021.
47 funds tracked by Wall St. Rank held Aceragen Inc as of Q2 2021.

Based on Meridian Wealth Partners's 13F filing for Q2 2021, filed 12 Aug 2021.